Lv11
30 积分 2023-05-07 加入
The landscape of ATF3 in tumors: metabolism, expression regulation, therapy approach, and open concerns
1小时前
待确认
Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis
2小时前
已完结
Metabolic engineering to facilitate anti-tumor immunity
26天前
已完结
Navigating CAR-T cells through the solid-tumour microenvironment
27天前
已完结
CAR-T therapy in solid tumors
28天前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
29天前
已完结
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
1个月前
已完结
WEE1 Confers Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
1个月前
已完结
Diterpenoid Vinigrol specifically activates ATF4/DDIT3-mediated PERK arm of unfolded protein response to drive non-apoptotic death of breast cancer cells
1个月前
已完结
Tumour heterogeneity and resistance to cancer therapies
1个月前
已完结
皖公网安备34019202002308
